Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham Alabama 35294

A clinical research study of Standard dose cytarabine for induction, SGN-CD33A, Daunorubicin and High dose cytarabine for consolidation for the treatment of Acute Myeloid Leukemia or Acute Myelogenous Leukemia (AML)

Birmingham Alabama 35294

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

View More ▼

Birmingham Alabama 35233

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249-6909

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia

Huntsville Alabama 35805

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

Huntsville Alabama 35805

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Mobile Alabama 36604

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Alaska

Anchorage Alaska 99503

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Arizona

Arizona Center for Cancer Care
Glendale Arizona

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Arizona Oncology Associates
Phoenix Arizona

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Mayo Clinic
Phoenix Arizona

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

View More ▼

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Chandler Arizona 85224

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

Chandler Arizona 85224

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Glendale Arizona 85308

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Oro Valley Arizona 85755

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona 85054

A Phase 3 clinical study for patients with Chronic Lymphocytic Leukemia, High Risk

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Apixaban and No systemic anticoagulant prophylaxis for the treatment of Lymphoma or Acute Lymphoblastic Leukemia

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Phoenix Arizona 85027

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia

Scottsdale Arizona 85259

A clinical trial to evaluate treatments using FLX925 for patients with Acute Myeloid Leukemia

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study for the treatment of Chronic Lymphocytic Leukemia (CLL)

Scottsdale Arizona 85259-5499

Patients are needed to participate in a clinical research study of SGI-110 (guadecitabine) and Treatment Choice to evaluate Acute Myeloid Leukemia (AML)

Tucson Arizona 85724-5024

Patients are needed to participate in a clinical research study evaluating Duvelisib and Venetoclax for the treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Tucson Arizona 85704

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Arkansas

Genesis Cancer Center
Hot Springs Arkansas

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

View More ▼

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Jonesboro Arkansas 72401

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Little Rock Arkansas 72202

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia

California

Pacific Cancer Medical Center Inc
Anaheim California

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

Pacific Cancer Medical Center Inc
Anaheim California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

City of Hope National Medical Center
Duarte California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

UC San Diego Moores Cancer Center
La Jolla California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Southern California Oncology Research Alliance
Los Angeles California

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

UCLA Hematology/Oncology
Los Angeles California

ACE-CL-007: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 Monotherapy in Subjects With Previously Untreated CLL

UCLA Hematology/Oncology
Los Angeles California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Southern California Oncology Research Alliance
Los Angeles California

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia